Rodrigo Martins is full professor at FCT-NOVA- Portugal, President of the European Academy of Sciences; President of the International Union of Materials Research Societies; Full Professor at FCT-NOVA. Member of the:
Rodrigo Martins is the founder and director of the Centre of Excellence in Microelectronics and Optoelectronics Processes of Uninova; leader of the Materials, Optoelectronics and Nanotechnologies group of I3N/CENIMAT and its sub-director; member of the nomination committee of the EIT KIC Raw Materials, Editor in Chief of the journal Discover Materials. He is expert in the field of advanced functional materials, nanotechnologies, microelectronics, transparent electronics (pioneer) and paper electronics (inventor), with more than:
- 1050 papers, from which 677 in the WoK
- 2 books; editing 8 books; 1 pedagogic text book in Portuguese (900 pages); book chapters 28.
- Patents: granted patents 43; 16 pending.
- Talks: about 600 talks, from which 100 as plenary/key note speakers, 200 as invited and 200 as regular in main international and national conferences, symposia and workshops.
- Posters: about 300 in main international and national conferences, symposia and workshops
He is Member of the:
Rodrigo Martins was decorated with the gold medal of merit and distinction by the Almada Municipality for his R&D achievements. ORCID: http://orcid.org/0000-0002-1997-7669: Webpage: https://cemop.uninova.pt/ Click here for more details.
Dr. Nathalie Mignet is Research Director at the National Center for Scientific Research (CNRS) in France. She is the leader of the Laboratory Chemical and Biological Technologies for Health located at Université de Paris Cité, at the faculty of Pharmacy.
After a PhD in France in organic chemistry, Dr Mignet was hired by the company Lynx Therapeutics in San Francisco. She then joined the University of Sheffield in UK for one year before being hired by the French biotech company Capsulis to work on onion-based nanoparticles called spherulites. She joined the CNRS as a research Scientist in 2000 to work on non-viral gene delivery. Since then, she expanded her domain of interest from drug delivery systems to nanomedicine designed for triggered delivery or imaging.
With her lab (#Mignet Lab), she is interested in nanomedicine for delivery or imaging going from fundamental to preclinical studies mostly in cancer.
She is also the founder and the former president of the French Society for Nanomedecine, SFNano.